Background Closed-loop artificial pancreas systems have been in development for several
years, including assessment in numerous varied outpatient clinical trials. We aimed to …

Automated insulin delivery (AID) systems, so-called closed-loop systems or artificial
pancreas, are based upon the concept of insulin supply driven by blood glucose levels and …

Background An artificial pancreas (AP) that can be worn at home from dinner to waking up in
the morning might be safe and efficient for first routine use in patients with type 1 diabetes …

OBJECTIVE We evaluated the effect of the MD-Logic system on overnight glycemic control
at patients' homes. RESEARCH DESIGN AND METHODS Twenty-four patients (aged 12–43 …

OBJECTIVE To evaluate two widely used control algorithms for an artificial pancreas (AP)
under nonideal but comparable clinical conditions. RESEARCH DESIGN AND METHODS …

Despite the continuous efforts devoted to AP development in the last decades, an artificial
pancreas (AP) system is not yet available on the market. One of the major issues involves …

Background: In the past few years, the artificial pancreas—the commonly accepted term for
closed-loop control (CLC) of blood glucose in diabetes—has become a hot topic in research …

Objectives The main purpose of the article is to raise awareness among all the involved
stakeholders about the risks and legal implications connected to the development and use …

A novel meal-detection algorithm is developed based on continuous glucose
measurements. Bergman's minimal model is modified and used in an unscented Kalman …

Background Closed-loop insulin delivery is a promising option to improve glycaemic control
and reduce the risk of hypoglycaemia. We aimed to assess whether overnight home use of …